Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies.
作者信息
Morris Jeffrey S
机构信息
Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
出版信息
J Natl Cancer Inst. 2022 Jan 11;114(1):5-6. doi: 10.1093/jnci/djab188.
Abstract
摘要
相似文献
1
Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies.无病生存期是结直肠癌研究中总生存期的一个有前景的替代指标。
J Natl Cancer Inst. 2022 Jan 11;114(1):5-6. doi: 10.1093/jnci/djab188.
2
Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer.将肿瘤反应和无进展生存期联合作为晚期结直肠癌总生存期的替代终点。
Cancer Epidemiol. 2020 Feb;64:101665. doi: 10.1016/j.canep.2019.101665. Epub 2020 Jan 5.
3
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature.无进展生存期作为替代终点和真实终点：来自乳腺癌和结直肠癌文献的见解。
Ann Oncol. 2010 Jan;21(1):7-12. doi: 10.1093/annonc/mdp523. Epub 2009 Nov 9.
4
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal Cancer.多机构临床基因组队列中非小细胞肺癌或结直肠癌患者替代终点与总生存的相关性。
JAMA Netw Open. 2021 Jul 1;4(7):e2117547. doi: 10.1001/jamanetworkopen.2021.17547.
5
Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence.热灌注腹腔化疗治疗结直肠癌腹膜转移：新证据
Clin Colorectal Cancer. 2020 Mar;19(1):1-4. doi: 10.1016/j.clcc.2019.10.003. Epub 2020 Jan 2.
6
Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.Brahma 基因启动子区域的两个功能缺失多态性与结直肠癌的疾病风险和无进展生存。
PLoS One. 2018 Jun 12;13(6):e0198873. doi: 10.1371/journal.pone.0198873. eCollection 2018.
7
Prognostic impact of postoperative intra-abdominal infections after elective colorectal cancer resection on survival and local recurrence: a propensity score-matched analysis.择期结直肠癌切除术后腹腔内感染对生存和局部复发的预后影响：一项倾向评分匹配分析
Int J Colorectal Dis. 2020 Mar;35(3):413-422. doi: 10.1007/s00384-019-03493-x. Epub 2020 Jan 2.
8
Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors.无进展生存期可作为晚期实体瘤靶向治疗临床试验中总生存期的替代指标。
Drugs. 2017 May;77(7):713-719. doi: 10.1007/s40265-017-0728-y.
9
Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer.对随机对照试验的荟萃分析表明，晚期结直肠癌总生存替代结局的有效性欠佳。
J Clin Epidemiol. 2015 Jul;68(7):833-42. doi: 10.1016/j.jclinepi.2015.02.016. Epub 2015 Mar 6.
10
[Overall survival: is it an objective endpoint for assessing the quality of surgical treatment for colorectal cancer?].
Rozhl Chir. 2013 Dec;92(12):690-3.
引用本文的文献
1
Predicting disease-free survival following curative-intent resection of right-sided colon cancer using a pre- and post-operative nomogram: a prospective observational cohort study.使用术前和术后列线图预测右半结肠癌根治性切除术后的无病生存期：一项前瞻性观察性队列研究。
Int J Surg. 2025 Apr 1;111(4):2886-2893. doi: 10.1097/JS9.0000000000002300.
2
Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial.3D 与 2D 腹腔镜胃癌根治术的长期肿瘤学结果：一项随机临床试验。
Gastric Cancer. 2024 May;27(3):598-610. doi: 10.1007/s10120-024-01470-0. Epub 2024 Feb 20.
3
Meta-analysis of the effect of laparoscopic surgery and open surgery on long-term quality of life in patients with colorectal cancer.腹腔镜手术与开腹手术对结直肠癌患者长期生活质量影响的荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34922. doi: 10.1097/MD.0000000000034922.
本文引用的文献
1
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.重新评估 III 期辅助结肠癌试验中无病生存作为终点与总生存的关系。
J Natl Cancer Inst. 2022 Jan 11;114(1):60-67. doi: 10.1093/jnci/djab187.
Zotero 插件